Skip to content

Alpha Cognition ACOG Cash & Equivalents

Cash & Equivalents at other companies

Biogen logo
BiogenBIIB
$3.38B+30.2%
AbbVie logo
AbbVieABBV
$9.39B+81.5%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$110.73M+61.3%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$282.21M+29.6%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$311.21M+108%
uniQure logo
uniQureQURE
$139.99M-35.6%

Other financials

Income statement

See full
Revenue$3.5M+20.7%
Gross profit$3.3M+12.7%
Operating income-$8.1M-138%
Net income-$6.5M-276%
EPS (diluted)-$0.32-191%

Balance sheet

See full
Total equity$57.5M+49.2%
Total assets$69.2M+42.5%

Cash flow

See full
Operating cash flow-$11.8M-477%
CapEx$1.3K-97.9%
Free cash flow-$11.8M-460%

Valuation

See full
Market cap$157.21M+6.6%
P/S14.5×

Profitability

See full
Gross margin89.3%
Operating margin-250.1%
Net margin-232.2%
FCF margin-280.5%

Returns & leverage

See full
Return on equity-52.4%-5.3pp
Current ratio12.6×-4.5×

Where this comes from

Reported directly by Alpha Cognition in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Alpha Cognition’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alpha Cognition's cash & equivalents?
Alpha Cognition (ACOG) reported cash & equivalents of $54.31M in Q1 2026.
How has Alpha Cognition's cash & equivalents changed year-over-year?
Alpha Cognition's cash & equivalents increased by 100637.7% year-over-year, from $53.91K to $54.31M.
What is the long-term trend for Alpha Cognition's cash & equivalents?
Over 3 years (2022 to 2025), Alpha Cognition's cash & equivalents has grown at a 216.6% compound annual growth rate (CAGR), from $2.08M to $66.11M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.